Post your job infront of 100,000+ qualified LP's and GP's.
Recently Filled Jobs
Firms you might be interested in
Posted on: Nov. 3, 2017, 11:31 p.m.
New York-based life sciences private equity company Aisling Capital has raised $280 million capital commitments for its latest fund to focus on bringing breakthrough medical treatments to market. With the new fund, Aisling will assist companies developing therapeutics to complete their clinical studies, navigate approval and ultimately reach commercialization, the company said. “Today, every biotech company must develop treatments that generate significant upside for patient care through profound impact on disease, fewer side effects, and a shift away from toxic ... Full investment news articleRelevent to this post: Louisiana Economic Development,